JGAR is now Open Access!
As of January 2020, the Journal of Global Antimicrobial Resistance (JGAR) is a fully open access journal with no subscription charges!
Authors publishing in JGAR can make their work immediately, permanently, and freely accessible to researchers worldwide.
JGAR authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright to their published work.
The APC will be requested after peer review and acceptance and will be required for all accepted articles submitted after 6 January 2020. The APC for JGAR is GBP 1500 (excluding taxes) for Original Research Articles and Review Articles and GBP 500 (excluding taxes) for Short Format Articles.
Please note: Authors who have submitted papers before 6 January 2020 will have their accepted paper published in JGAR at no charge. Authors submitting papers after this date will be requested to pay the APC.
About the Journal of Global Antimicrobial Resistance (JGAR)
JGAR is an official journal of and owned by the International Society of Antimicrobial Chemotherapy (ISAC), the Global Chinese Association of Clinical Microbiology and Infectious Diseases (GCACMID), and the Asia-Pacific Society of Clinical Microbiology and Infection (APSCMI). JGAR is published by Elsevier.
JGAR focuses on the global spread of antibiotic-resistant microbes and is a dedicated journal for all professionals working in research, health care, the environment and animal infection control, aiming to track the resistance threat worldwide and provides a single voice devoted to antimicrobial resistance (AMR).
For full information on publishing your paper open access in JGAR, visit the journal's open access page and guide for authors, or visit Elsevier's FAQs page.
February 18th-2020
